Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Autosomal dominant and sporadic late onset Alzheimer's disease share a commonin vivopathophysiology

Brain(2022)10.1093/brain/awac181Source: DataRank Database

Autosomal dominant and sporadic late onset Alzheimer's disease share a commonin vivopathophysiology is a research paper published in Brain (2022). On theSindex it has a DataRank of 1.4. It has been cited 62 times, with 43 citing works in its 1-hop citation network.

N/A

1.4DataRank · unranked

Scored on demand from live citation data

Open Access62 citations · 43 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)Impact (FWCI 5.72)OA: bronzeTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 43%Citation Network 57%

Base Score Contribution

0.621

From this paper's citation signal

Citation Network Contribution

0.827

From 29 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 43 citers.

Events in the brain during the evolution of Alzheimer’s disease
Nature Medicine20231 citations5 referencesContributes 0.139
γ-Secretase: once and future drug target for Alzheimer’s disease
Expert Opinion on Drug Discovery202313 citations21 referencesContributes 0.126
Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease
Alzheimer s & Dementia202253 citations49 referencesContributes 0.081
Is Alzheimer disease a disease?
Nature Reviews Neurology2024172 citations93 referencesContributes 0.055
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide production
eLife20248 citations45 referencesContributes 0.049

Authors (45)

Michael W. Weiner ORCID,Johannes Levin ORCID,Laurel Beckett ORCID,Dean W. Coble ORCID,Naomi Saito ORCID

Live enrichment

PubMed:35580594 PMC:PMC9989348 OpenAlex:https://openalex.org/W4280526065

Alzheimer’s Association

Grant: DIAN_ADNI-16-434364

Dominantly Inherited Alzheimer Network

Grant: U19AG032438

Japan Agency for Medical Research and Development

Grant: NP21dk0207049

Dementias Platform UK

Grant: MR/L023784/1

UK Dementias Platform

Dementias Platform UK

Grant: MR/009076/1

NIA NIH HHS

Grant: UF1 AG032438

NIA NIH HHS

Grant: P01 AG003991

NIA NIH HHS

Grant: P30 AG072979

NIA NIH HHS

Grant: K01 AG053474

NIH HHS

Grant: S10 OD025214

NIA NIH HHS

Grant: P01 AG026276

NIA NIH HHS

Grant: P30 AG066530

NIA NIH HHS

Grant: P30 AG066462

NIA NIH HHS

Grant: U19 AG024904

NIA NIH HHS

Grant: U01 AG024904

Medical Research Council

Grant: UKDRI-1001

National Institutes of Health

Grant: 1U01AG024904-01

Alzheimers Disease Neuroimaging Initiative

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5U19AG032438-03

DIAN Genetics Core

UCL/UCLH

Biomedical Research Centre

National Institute for Health Research (NIHR)

German Center for Neurodegenerative Diseases

NIH

National Institute on Aging

Institute for Neurological Research

FWCI

5.72

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/brain/article-pdf/145/10/3594/49426553/awac181.pdf

publisherhttps://academic.oup.com/brain/article-pdf/145/10/3594/49426553/awac181.pdf

publisherhttps://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac181/45410031/awac181.pdf

journalhttps://doi.org/10.1093/brain/awac181

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35580594

Fields of Study

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchFunctional Brain Connectivity Studies03 medical and health sciences0302 clinical medicine

MeSH Terms

Alzheimer DiseaseAmyloidosisHumansMagnetic Resonance ImagingBiomarkersAmyloid beta-Peptides

Keywords

Alzheimer's diseaseEarly-onset Alzheimer's diseaseDementiaAlzheimer's Disease Neuroimaging InitiativeDiseasePathophysiologyMedicineAmyloid (mycology)Age of onsetCognitive declinePathologyNeuroimagingInternal medicineOncologyPsychiatryBiomarkersRates Of ChangeAlzheimer PathophysiologyAgingBiomedical and clinical scienceslzheimer pathophysiologyClinical Trials and Supportive ActivitiesMagnetic Resonance Imaging: methods610Alzheimer Disease: geneticsNeurodegenerativeMedical and Health SciencesClinical ResearchAlzheimer Disease616Health SciencesGeneticsAcquired Cognitive ImpairmentPsychology2.1 Biological and endogenous factorsHumansAlzheimer Disease: diagnostic imaginginfo:eu-repo/classification/ddc/610Neurology & NeurosurgeryAmyloid beta-PeptidesPsychology and Cognitive SciencesNeurosciencesAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)AmyloidosisMagnetic Resonance ImagingBrain DisordersNeurologicalBiomedical Imaging

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being